Filing Details

Accession Number:
0001600132-16-000066
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-18 13:46:32
Reporting Period:
2016-05-17
Filing Date:
2016-05-18
Accepted Time:
2016-05-18 13:46:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1600132 Bellerophon Therapeutics Inc. BLPH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1500241 M Jonathan Peacock C/O Bellerophon Therapeutics, Inc.
184 Liberty Corner Road, Suite 302
Warren NJ 07059
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-17 5,000 $1.37 222,702 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported represents the weighted average sales price of shares purchased in multiple transactions at prices ranging from $1.33 to $1.37 per share. The reporting person hereby undertakes upon the request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.